Patent · US Active

Quinoline derivatives and their use as tyrosine kinase inhibitors

US8957092B2 · kind B2 · utility

1Cited by

1References

6Claims

0Family size

Assignee

Clanotech AB · SE

Inventors

Jacob Westman · Järlåsa, SE
Natalia Nekhotiaeva · Solna, SE
Johan Wannberg · Uppsala, SE
Ulrika Backman · Uppsala, SE
Johan Malm · Älta, SE

Key dates

Filing date	Aug 30, 2013
Grant date	Feb 17, 2015
Priority date	—
Expiry date	Aug 30, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of formula

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.